Rac1 Protein Rescues Neurite Retraction Caused by G2019S Leucine-rich Repeat Kinase 2 (LRRK2)
Open Access
- 1 May 2011
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (18), 16140-16149
- https://doi.org/10.1074/jbc.m111.234005
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localizationBiochemical Journal, 2010
- Leucine-rich repeat kinase 2 induces α-synuclein expression via the extracellular signal-regulated kinase pathwayCellular Signalling, 2010
- Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after EndocytosisNeuron, 2010
- CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicityProceedings of the National Academy of Sciences, 2009
- Leucine-Rich Repeat Kinase 2 Mutations and Parkinson's Disease: Three QuestionsASN Neuro, 2009
- Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in DrosophilaThe EMBO Journal, 2008
- Wild-type LRRK2 but not its mutant attenuates stress-induced cell death via ERK pathwayNeurobiology of Disease, 2008
- Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPaseProceedings of the National Academy of Sciences, 2008
- LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activityBiochemical Journal, 2007
- The R1441C mutation of LRRK2 disrupts GTP hydrolysisBiochemical and Biophysical Research Communications, 2007